Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial (vol 16, 901846, 2022)

被引：1
|
作者：
Rahimlou, Mehran [1 ,2 ]
Nematollahi, Shima [1 ]
Husain, Durdana [1 ]
Banaei-Jahromi, Nasrin [3 ]
Majdinasab, Nastaran [4 ]
Hosseini, Seyed Ahmad [1 ]
机构：
[1] Ahvaz Jundishapur Univ Med Sci, Clin Sci Res Inst, Nutr & Metab Dis Res Ctr, Ahvaz, Iran
[2] Zanjan Univ Med Sci, Fac Med, Dept Nutr, Zanjan, Iran
[3] Ahvaz Jundishapur Univ Med Sci, Sch Allied Med Sci, Dept Nutr, Ahvaz, Iran
[4] Ahvaz Jundishapur Univ Med Sci, Sch Med, Dept Neurol, Ahvaz, Iran
来源：
FRONTIERS IN NEUROSCIENCE | 2022年 / 16卷
关键词：
probiotic; multiple sclerosis; inflammation; clinical trial; gut microbiome;
D O I：
10.3389/fnins.2022.1085572
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The probiotic supplementation reduced inflammation in polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial
    Ghanei, Nila
    Rezaei, Nima
    Amiri, Ghorban Ali
    Zayeri, Farid
    Makki, Golbou
    Nasseri, Esmat
    JOURNAL OF FUNCTIONAL FOODS, 2018, 42 : 306 - 311
  • [22] Glatiramer acetate in combination with minocycline in patients with relapsing-remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial
    Metz, L. M.
    Li, D.
    Traboulsee, A.
    Myles, M. L.
    Duquette, P.
    Godin, J.
    Constantin, M.
    Yong, V. W.
    MULTIPLE SCLEROSIS, 2009, 15 (10): : 1183 - 1194
  • [23] Effects of resveratrol supplementation on inflammatory markers, fatigue scale, fasting blood sugar and lipid profile in relapsing-remitting multiple sclerosis patients: a double-blind, randomized placebo-controlled trial
    Keramatzadeh, Sara
    Hosseini, Seyed Ahmad
    Majdinasab, Nastaran
    Cheraghian, Bahman
    Zilaee, Marzie
    NUTRITIONAL NEUROSCIENCE, 2024,
  • [24] CHOLECALCIFEROL SUPPLEMENTATION AND INFLAMMATION: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL
    Seibert, Eric
    Ulrich, Christof
    Trojanowicz, Bogusz
    Lehmann, Ulrike
    Dierkes, Jutta
    Stangl, Gabriele I.
    Girndt, Matthias
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [25] A Randomized, Double-Blind, Placebo-Controlled Study To Evaluate the Safety and Efficacy of Daclizumab HYP Monotherapy in Relapsing-Remitting Multiple Sclerosis: Primary Results of the SELECT Trial
    Gold, Ralf
    Giovannoni, Gavin
    Selmaj, Krzysztof
    Havrdova, Eva
    Montalban, Xavier
    Radue, Ernst-Wilhelm
    Stefoski, Dusan
    Robinson, Randy
    Riester, Katherine
    Elkins, Jacob
    O'Neill, Gilmore
    NEUROLOGY, 2012, 78
  • [26] The efficacy of cladribine in relapsing-remitting multiple sclerosis: Clinical data from a randomized, double-blind, placebo-controlled, 18-month, phase II trial
    Sipe, Jack
    Gardner, Jason
    Beutler, Ernest
    NEUROLOGY, 2008, 70 (11) : A90 - A91
  • [27] A randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of daclizumab HYP monotherapy in relapsing-remitting multiple sclerosis: primary results of the SELECT trial
    Giovannoni, G.
    Gold, R.
    Selmaj, K.
    Havrdova, E.
    Montalban, X.
    Radue, E. W.
    Stefoski, D.
    Robinson, R.
    Riester, K.
    Elkins, J.
    O'Neill, G.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S508 - S509
  • [28] Probiotic Supplementation in Chronic Kidney Disease: A Double-blind, Randomized, Placebo-controlled Trial
    Borges, Natalia A.
    Carmo, Flavia L.
    Stockler-Pinto, Milena B.
    de Brito, Jessyca S.
    Dolenga, Carla J.
    Ferreira, Dennis C.
    Nakao, Lia S.
    Rosado, Alexandre
    Fouque, Denis
    Mafra, Denise
    JOURNAL OF RENAL NUTRITION, 2018, 28 (01) : 28 - 36
  • [29] Pharmacokinetics and pharmacodynamics of PEGylated interferon beta-1a in patients with relapsing-remitting multiple sclerosis in the randomized double-blind placebo-controlled study
    Boyko, A.
    Alifirova, V.
    Boyko, O.
    Greshnova, I.
    Zaslavskiy, L.
    Zakharova, M.
    Parshina, E.
    Poverennova, I.
    Sazonov, D.
    Sokolova, I.
    Shur, S.
    Bakhtiyarova, K.
    Dudin, V.
    Khabirov, F.
    Zinkina-Orikhan, A.
    Linkova, Y.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 911 - 911
  • [30] RETRACTION: The effects of probiotic supplementation on gene expression related to inflammation, insulin, and lipids in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial
    Tamtaji, Omid Reza
    Kouchaki, Ebrahim
    Salami, Mahmoud
    Aghadavod, Esmat
    Akbari, Elmira
    Tajabadi-Ebrahimi, Maryam
    Asemi, Zatollah
    JOURNAL OF THE AMERICAN NUTRITION ASSOCIATION, 2024, 43 (06): : 568 - 568
12345